93216 ⎘
Derivatives of urea, i.e. compounds containing any of the groups , the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
UREA-BASED ICE RECRYSTALLIZATION INHIBITOR COMPOUNDS AND COMPOSITIONS, AND USES THEREOF FOR CRYOPRESERVATION
#2CHIRAL SPIROCYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF
#3DIAZONIUM COMPOUNDS AND METHODS OF USE FOR DNA CLEAVAGE
#4SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING BREAST CANCER
#5MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#6COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#7AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#8FPR2 (FORMYL PEPTIDE RECEPTOR 2)RECEPTOR AGONISTS AND THEIR USE IN THE TREATMENT OF THE AUTISM SPECTRUM DISORDER
#9DIPHENYL THIOUREA AND DIPHENYL UREA DERIVATIVES AS INHIBITORS OF ENDOCYTOSIS
#10PHENYL UREA ANALOGS AS FORMYL PEPTIDE RECEPTOR 1 (FPR1) SELECTIVE AGONISTS
#11MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#12SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING INFLAMMATORY CONDITIONS
#13SMALL MOLECULE INHIBITORS OF ENPP1
#14Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith
#15MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#16Heterodimers of Glutamic Acid
#17PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#18UREA DERIVATIVES AS CB1 ALLOSTERIC MODULATORS
#19NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF
#20AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#21NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE
#22MYC-MAX INHIBITOR COMPOUND THERAPEUTICS FOR CANCER TREATMENT, METHODS AND USES ASSOCIATED THEREWITH
#23Compositions and methods for the treatment of cancer
#24[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
#25SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING BREAST CANCER
#26CHEMICAL COMPOUNDS
#27HETERODIMERS OF GLUTAMIC ACID
#28MODULATORS OF TRYPTOPHAN CATABOLISM
#29Fatty acid analogues and methods of use
#30Phenyl urea derivatives as N-formyl peptide receptor modulators
#31hTRPV1 chemical agents
#32NOVEL UREA COMPOUNDS AND BIOISOSTERES THEREOF AND THEIR USE FOR TREATING INFLAMMATION AND INFLAMMATION-RELATED PATHOLOGIES
#33HETERODIMERS OF GLUTAMIC ACID
#34HETERODIMERS OF GLUTAMIC ACID
#35MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#36Treating and preventing diseases by modulating cell mechanics
#37Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#38Substituted bisphenylalkylurea compounds and methods
#39PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#40PHENYL UREA ANALOGS AS FORMYL PEPTIDE RECEPTOR 1 (FPR1) SELECTIVE AGONISTS
#41T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS
#42Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#43Heterodimers of glutamic acid
#44Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#45Phenyl urea derivatives as n-formyl peptide receptor modulators
#46N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease
#47Treating and preventing diseases by modulating cell mechanics
#48Urea derivative and use therefor
#49Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#50Oil gelator
#51PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#52Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#53HTRPVI chemical agents
#54Urea derivative or pharmacologically acceptable salt thereof
#55Heterodimers of glutamic acid
#56Inhibitors of histone deacetylase
#57METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND ITS PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE
#58Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#59Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#60INHIBITORS OF HISTONE DEACETYLASE
#61T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#62Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#63SUBSTITUTED TETRACYCLINE COMPOUNDS
#64IDO inhibitors
#65Carbamoyl hydrazine derivatives as formyl peptide modulators
#66OMEGA-3 ANALOGUES
#67Use of DDX3X inhibitors for the treatment of pneumovirus infections
#68Immunoregulatory agents
#69Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#70Tripodal nitrate receptor
#71Heterodimers of glutamic acid
#72PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#73Bioinspired catalysis using oligourea helical foldamers
#74Inhibitors of histone deacetylase
#75N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#76Substituted Urea eIF2alpha Kinase Activators
#77Heterodimers of glutamic acid
#78Inhibitors of histone deacetylase
#79Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#80Methods and compositions for selective and targeted cancer therapy
#81OMEGA-3 ANALOGUES
#82Compounds and methods for treating mammalian gastrointestinal microbial infections
#83PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#84Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#85Compounds and methods for treating mammalian gastrointestinal microbial infections
#86Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#87Use of T1R3 venus flytrap region polypeptide to screen for taste modulators
#88COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR
#89Substituted tetracycline compounds
#90Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators
#91Separating agent and manufacturing method thereof
#922-substituted--quinone derivatives for treatment of oxidative stress diseases
#93Kinase inhibitors
#94TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS
#95Modulators of development of adipocyte and cancer cells
#96Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#97Sorafenib derivatives as sEH inhibitors
#98Inhibitors of histone deacetylase
#99Inhibitors of histone deacetylase
#100Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
#101Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
#102PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES
#103Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
#104TRPV1 antagonists
#105Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
#106Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#107T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#108COMPOUNDS AND THERAPEUTIC USES THEREOF
#109DERIVATIVES OF BETULIN
#1109-substituted minocycline compounds
#111Heterodimers of glutamic acid
#112Heterodimers of glutamic acid
#113Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#1142-adamantylurea derivatives as selective 11β-HSD1 inhibitors
#115Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#116Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
#117Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
#118N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#119Compounds and methods for treating mammalian gastrointestinal microbial infections
#120Sphingosine kinase inhibitors
#121OMEGA CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
#122Preparation of monobasic phosphate ionophores
#123Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
#1242-substituted--quinone derivatives for treatment of oxidative stress diseases
#125Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#126Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#127Probes, Systems, and Methods for Drug Discovery
#128Process for production of heterodimers of glutamic acid
#129Process for the preparation of a RAF kinase inhibitor and intermediates for use in the process
#130SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#131Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#132PRODRUGS OF 9-AMINOMETHYL TETRACYCLINE COMPOUNDS
#133Pyrimidine compound and medical use thereof
#134New Methylenebisphenyl Compounds Useful in the Treatment of Inflammation
#135Regulating Agent of GPR34 Receptor Function
#136Chiral cyclic β-amino acids and their derivatives, pharmaceutical compositions containing them and the use of such compounds
#137Rho kinase inhibitors
#138Inhibitors for the soluble epoxide hydrolase
#1399-substituted minocycline compounds
#140N- (2-aminophenyl) benzamide derivative having urea structure
#141Substituted amides
#142Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#143Indane amides
#1442-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
#145Compounds, Compositions and Methods
#146Glucagon Antagonists/Inverse Agonists
#147Plasminogen activator inhibitor-1 inhibitor
#148Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#149SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#150Antithrombotic diamides
#151Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#152Diphenyl Urea Derivatives
#153SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#154Diphenyl urea derivatives
#155PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#156Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions
#157Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
#158ANTIVIRAL INHIBITION OF CAPSID PROTEINS
#159Process for the preparation of "Urchym" a urease and alpha-chymotrypsin enzyme inhibitory drug
#160C5a receptor antagonists
#161Methods and compositions for the treatment of body composition disorders
#162Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
#163Methods and compositions for the treatment of pain, inflammation and cancer
#164Heterodimers of glutamic acid
#165Substituted pyridyoxy amides
#166Sphingosine kinase inhibitors
#167Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
#168ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE
#169Ethylenically unsaturated group-containing isocyanate compound and process for producing the same, and reactive monomer, reactive (meth) acrylate polymer and its use
#170Partially fluorinated compositions and surface active agents
#171Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
#172Organic Compunds
#173Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
#174Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
#175Tetradydro-Naphthalene And Urea Derivatives
#176Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
#177Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
#178Novel Biphenyl Compounds And Their Use
#179Phenethanolamine derivatives for treatment of respiratory diseases
#180Malonamides and malonamide derivatives as modulators of chemokine receptor activity
#181Benzimidazolyl derivatives
#182Novel urea derivatives and their medical use
#183Benzene compounds
#184T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#185Peptidomimetic ligands for cellular receptors and ion channels
#186Sphingosine kinase inhibitors
#187Prodrugs of 9-aminomethyl tetracycline compounds
#188Ether derivative
#189Compounds, compositions, and methods
#190Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
#191Diarylurea derivatives and their use as chloride channel blockers
#192Ureas as factor Xa inhibitors
#1932,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
#194Amide compounds for the potentiation of cholinergic activity
#195Novel aryl urea analogs and use thereof as antibacterial agents
#196Pyrimidine compound and medical use thereof
#197Use of urea variants as affinity ligands
#198Benzoic acid derivatives as modulators of PPAR alpha and gamma
#199Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions
#200Substituted amides
#201Novel anticancer compounds
#202Phenethanolamine derivatives for treatment of respiratory diseases
#203Glucagon antagonists/inverse agonists
#2042,3-Oxidosqualene-lanosterol cyclase inhibitors
#205Inhibitors for the soluble epoxide hydrolase
#206Compounds, compositions and methods
#207Urea derivatives
#208N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
#209Substituted tetracycline compounds
#210Carboxamide derivatives
#211Prodrugs of 9-aminomethyl tetracycline compounds
#212Acetylene derivatives as inhibitors of histone deacetylase
#213Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#214Peptidomimetic ligands for cellular receptors and ion channels
#215Glucagon antagonists/inverse agonists
#216Substituted urea neuropeptide Y Y5 receptor antagonists
#217Inhibitors for the soluble epoxide hydrolase
#218Urea linker derivatives for use as PPAR modulators